Skip to main content
SpringerLink
Log in

Predictors of Clinical Recovery in Bipolar Disorders

  • Chapter
  • First Online:
Recovery and Major Mental Disorders

Part of the book series: Comprehensive Approach to Psychiatry ((CAP,volume 2))

Abstract

Patients with bipolar disorders may experience serious impairments in psychosocial functioning and quality of life, despite adequate treatment. Numerous treatments are available for acute affective episodes, in most cases promoting symptomatic remission from affective episodes. Symptomatic remission does not necessarily lead to an acceptable level of functioning, defined as full recovery. Full recovery in bipolar disorder is mostly hampered by cognitive impairment and subclinical depressive symptoms, defined as residual symptoms. The aim of this chapter is to give an insight into the concept of clinical recovery in bipolar disorders, going from symptomatic remission and the available treatment strategies to a wider spectrum of new opportunities in the management of bipolar disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carvalho AF, Firth J, Vieta E. Bipolar disorder. N Engl J Med. 2020;383(1):58–66.

    Article  CAS  PubMed  Google Scholar 

  2. APA. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Association; 2013.

    Google Scholar 

  3. He H, Hu C, Ren Z, Bai L, Gao F, Lyu J. Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: results from the global burden of disease study 2017. J Psychiatr Res. 2020;125:96–105.

    Article  PubMed  Google Scholar 

  4. Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Müller-Oerlinghausen B, Berghöfer A, Bauer M. Bipolar disorder. Lancet (London, England). 2002;359(9302):241–7.

    Article  Google Scholar 

  6. Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders—a life-long perspective. Acta Psychiatr Scand. 2004;109(5):339–44.

    Article  CAS  PubMed  Google Scholar 

  7. Martínez-Arán A, Vieta E, Colom F, Reinares M, Benabarre A, Gastó C, et al. Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom. 2000;69:2–18.

    Article  PubMed  Google Scholar 

  8. Martínez-Arán A, Vieta E, Colom F, Torrent C, Sánchez-Moreno J, Reinares M, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224–32.

    Article  PubMed  Google Scholar 

  9. Bonnín CM, Martínez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1–2):156–60.

    Article  PubMed  Google Scholar 

  10. Rosa AR, González-Ortega I, González-Pinto A, Echeburúa E, Comes M, Martínez-Àran A, et al. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand. 2012;125(4):335–41.

    Article  CAS  PubMed  Google Scholar 

  11. Tohen M, Hennen J, Zarate CMJ, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157(2):220–8.

    Article  CAS  PubMed  Google Scholar 

  12. Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes. 2005;3(1):72. https://doi.org/10.1186/1477-7525-3-72.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rosa AR, Franco C, Martinez-Aran A, Sanchez-Moreno J, Reinares M, Salamero M, et al. Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom. 2008:390–2.

    Google Scholar 

  14. Tohen M, Bowden CL, Calabrese JR, Lin D, Forrester TD, Sachs GS, et al. Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Br J Psychiatry. 2006;189(6):515–9. https://www.cambridge.org/core/article/influence-of-subsyndromal-symptoms-after-remission-from-manic-or-mixed-episodes/DB176EF66B0977711D331D1434A0E06A.

    Article  PubMed  Google Scholar 

  15. del Mar Bonnín C, Reinares M, Martínez-Arán A, Jiménez E, Sánchez-Moreno J, Solé B, et al. Improving functioning, quality of life, and well-being in patients with bipolar disorder. Int J Neuropsychopharmacol. 2019;22(8):467–77. https://doi.org/10.1093/ijnp/pyz018.

    Article  CAS  Google Scholar 

  16. Schrank B, Slade M. Recovery in psychiatry. Psychiatr Bull. 2007;31(9):321–5. https://www.cambridge.org/core/article/recovery-in-psychiatry/1D707A2B60C5622D7028D79A84F79C2D.

    Article  Google Scholar 

  17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., Text Revision). Washington: Author; 2000.

    Google Scholar 

  18. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–73. https://doi.org/10.1111/j.1399-5618.2009.00726.x.

    Article  PubMed  Google Scholar 

  19. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73(3):159–71.

    Article  CAS  PubMed  Google Scholar 

  20. Berk M, Ng F, Wang WV, Calabrese JR, Mitchell PB, Malhi GS, et al. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord. 2008;106(1–2):153–8.

    Article  PubMed  Google Scholar 

  21. Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. J Affect Disord. 2008;107(1):169–74. http://www.sciencedirect.com/science/article/pii/S0165032707002893.

    Article  CAS  PubMed  Google Scholar 

  22. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gignac A, McGirr A, Lam RW, Yatham LN. Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. J Clin Psychiatry. 2015;76(9):1241–8.

    Article  PubMed  Google Scholar 

  24. Anmella G, Gil-Badenes J, Pacchiarotti I, Verdolini N, Aedo A, Angst J, et al. Do depressive and manic symptoms differentially impact on functioning in acute depression? Results from a large, cross-sectional study. J Affect Disord. 2020a;261:30–9.

    Article  PubMed  Google Scholar 

  25. Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry. 2006;11(3):227–40. https://doi.org/10.1038/sj.mp.4001793.

    Article  CAS  PubMed  Google Scholar 

  26. Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, et al. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. Br J Psychiatry. 2019;214(1):27–35.

    Article  PubMed  Google Scholar 

  27. Esan O, Osunbote C, Oladele O, Fakunle S, Ehindero C, Fountoulakis KN. Bipolar I disorder in remission vs. schizophrenia in remission: is there a difference in burden? Compr Psychiatry. 2017;72:130–5. http://www.sciencedirect.com/science/article/pii/S0010440X16303637.

    Article  PubMed  Google Scholar 

  28. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller H-J, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.

    Article  PubMed  Google Scholar 

  29. Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), Part 3: the clinical guidelines. Int J Neuropsychopharmacol. 2016;20(2):180–95. https://doi.org/10.1093/ijnp/pyw109.

    Article  PubMed Central  Google Scholar 

  30. Pacchiarotti I, Anmella G, Colomer L, Vieta E. How to treat mania. Acta Psychiatr Scand. 2020a;142:173–92.

    Article  CAS  PubMed  Google Scholar 

  31. Grande I, Vieta E. Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics? CNS Drugs. 2015;29(3):221–7.

    Article  CAS  PubMed  Google Scholar 

  32. Yildiz A, Nikodem M, Vieta E, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med. 2015;45(2):299–317.

    Article  CAS  PubMed  Google Scholar 

  33. Ciapparelli A, Dell’Osso L, Tundo A, Pini S, Chiavacci MC, Di Sacco I, et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry. 2001;62(7):552–5. https://doi.org/10.4088/jcp.v62n07a09.

    Article  CAS  PubMed  Google Scholar 

  34. Bobo WV, Reilly-Harrington NA, Ketter TA, Brody BD, Kinrys G, Kemp DE, et al. Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study. J Clin Psychopharmacol. 2015;35(1):68–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, et al. Empirically supported psychosocial interventions for bipolar disorder: current state of the research. J Affect Disord. 2016;201:203–14. http://www.sciencedirect.com/science/article/pii/S0165032716303743.

    Article  PubMed  Google Scholar 

  36. Miller S, Dell’Osso B, Ketter TA. The prevalence and burden of bipolar depression. J Affect Disord. 2014;169:S3–11. http://www.sciencedirect.com/science/article/pii/S0165032714700035.

    Article  PubMed  Google Scholar 

  37. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530–7.

    Article  PubMed  Google Scholar 

  38. DelBello MP, Goldman R, Phillips D, Deng L, Cucchiaro J, Loebel A. Efficacy and safety of lurasidone in children and adolescents with Bipolar I depression: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2017;56(12):1015–25.

    Article  PubMed  Google Scholar 

  39. Pinto JV, Saraf G, Vigo D, Keramatian K, Chakrabarty T, Yatham LN. Cariprazine in the treatment of bipolar disorder: a systematic review and meta-analysis. Bipolar Disord. 2020;22(4):360–71.

    Article  CAS  PubMed  Google Scholar 

  40. Szmulewicz AG, Angriman F, Samamé C, Ferraris A, Vigo D, Strejilevich SA. Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand. 2017;135(6):527–38.

    Article  CAS  PubMed  Google Scholar 

  41. Rosenblat JD, Kakar R, Berk M, Kessing LV, Vinberg M, Baune BT, et al. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord. 2016;18(2):89–101.

    Article  CAS  PubMed  Google Scholar 

  42. Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, et al. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016;46(7):1459–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mccloud TL, Caddy C, Jochim J, Rendell JM, Diamond PR, Shuttleworth C, et al. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev. 2015;(9):CD011611.

    Google Scholar 

  44. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249–62. https://www.ncbi.nlm.nih.gov/pubmed/24030475.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Nivoli AMA, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, et al. New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord. 2011;129(1):14–26. http://www.sciencedirect.com/science/article/pii/S0165032710004039.

    Article  PubMed  Google Scholar 

  46. Ross EL, Zivin K, Maixner DF. Cost-effectiveness of electroconvulsive therapy vs pharmacotherapy/psychotherapy for treatment-resistant depression in the United States. JAMA Psychiat. 2018;75(7):713–22. https://doi.org/10.1001/jamapsychiatry.2018.0768.

    Article  Google Scholar 

  47. Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry. 2008;165(11):1408–19. https://doi.org/10.1176/appi.ajp.2008.08040488.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M, et al. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry. 2017;16(3):308–15. https://doi.org/10.1002/wps.20458.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Pacchiarotti I, Kotzalidis GD, Murru A, Mazzarini L, Rapinesi C, Valentí M, et al. Mixed features in depression: the unmet needs of diagnostic and statistical manual of mental disorders fifth edition. Psychiatr Clin North Am. 2020b;43(1):59–68. http://www.sciencedirect.com/science/article/pii/S0193953X19300991.

    Article  PubMed  Google Scholar 

  50. Vieta E, Valentí M. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord. 2013;148(1):28–36.

    Article  PubMed  Google Scholar 

  51. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Azorin J-M, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: acute and long-term treatment of mixed states in bipolar disorder. World J Biol Psychiatry. 2017;19(1):2–58.

    Article  PubMed  Google Scholar 

  52. Stahl SM. Mixed-up about how to diagnose and treat mixed features in major depressive episodes. CNS Spectr. 2017;22(02):111–5.

    Article  PubMed  Google Scholar 

  53. Akiskal HS, Benazzi F, Perugi G, Rihmer Z. Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord. 2005;85(3):245–58. http://www.sciencedirect.com/science/article/pii/S0165032704004343

    Article  PubMed  Google Scholar 

  54. Murru A. Electroconvulsive therapy in bipolar mixed states: an overlooked option. J Clin Psychiatry. 2015:e1149–50.

    Google Scholar 

  55. Verdolini N, Hidalgo-Mazzei D, Murru A, Pacchiarotti I, Samalin L, Young AH, et al. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatr Scand. 2018;138(3):196–222. https://doi.org/10.1111/acps.12896.

    Article  CAS  PubMed  Google Scholar 

  56. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H. Recurrence of bipolar disorders and major depression. Eur Arch Psychiatry Clin Neurosci. 2003;253(5):236–40. https://doi.org/10.1007/s00406-003-0437-2.

    Article  PubMed  Google Scholar 

  57. Keck PEJ, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry. 2007;68(10):1480–91.

    Article  CAS  PubMed  Google Scholar 

  58. Perlis RH, Delbello MP, Miyahara S, Wisniewski SR, Sachs GS, Nierenberg AA. Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatry. 2005;58(7):549–53.

    Article  PubMed  Google Scholar 

  59. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006;163(2):217–24. https://doi.org/10.1176/appi.ajp.163.2.217.

    Article  PubMed  Google Scholar 

  60. Murru A, Verdolini N, Anmella G, Pacchiarotti I, Samalin L, Aedo A, et al. A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients. Eur Psychiatry. 2019;61:1–8.

    Article  PubMed  Google Scholar 

  61. Murru A, Pacchiarotti I, Verdolini N, Reinares M, Torrent C, Geoffroy PA, et al. Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2017;268:749–55.

    Article  PubMed  Google Scholar 

  62. Nivoli AMA, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology. 2010;62:27–35.

    Article  CAS  PubMed  Google Scholar 

  63. Anmella G, Vieta E, Hidalgo-Mazzei D. Commentary on: “Make lithium great again!”. Bipolar Disord. 2020b;

    Google Scholar 

  64. Baldessarini R, Tondo L, Vázquez G. Lithium treatment for bipolar disorder. Bipolar Disord. Bipolar Disord; 2020.

    Google Scholar 

  65. Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(5):351–9.

    Article  PubMed  Google Scholar 

  66. Geddes JR, Goodwin GM, Rendell J, Morriss R, Alder N, Juszczak E, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar i disorder (BALANCE): a randomised open-label trial. Lancet. 2010;375(9712):385–95.

    Article  PubMed  CAS  Google Scholar 

  67. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290(11):1467–73. https://doi.org/10.1001/jama.290.11.1467.

    Article  CAS  PubMed  Google Scholar 

  68. Murru A, Popovic D, Pacchiarotti I, Hidalgo D, León-Caballero J, Vieta E. Management of adverse effects of mood stabilizers. Curr Psychiatry Rep. 2015;17(8):66.

    Article  Google Scholar 

  69. Samalin L, Murru A, Vieta E. Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother. 2016b;16:659–70.

    Article  CAS  PubMed  Google Scholar 

  70. Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 2013;2013(10):CD003196. https://pubmed.ncbi.nlm.nih.gov/24132760.

    PubMed Central  Google Scholar 

  71. Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 2006;93(1–3):13–7.

    Article  CAS  PubMed  Google Scholar 

  72. Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, et al. Bipolar disorders. Nat Rev Dis Prim. 2018;4:18008.

    Article  PubMed  Google Scholar 

  73. Popovic D, Reinares M, Goikolea JM, Bonnin CM, Gonzalez-Pinto A, Vieta E. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol. 2012;22(5):339–46.

    Article  CAS  PubMed  Google Scholar 

  74. Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495–553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust New Zeal J Psychiatry. 2015;49(12):1087–206.

    Article  Google Scholar 

  76. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152(11):1635–40.

    Article  CAS  PubMed  Google Scholar 

  77. Murru A, Pacchiarotti I, Nivoli AMA, Bonnin CM, Patrizi B, Amann B, et al. Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients. Acta Psychiatr Scand. 2012;125(5):412–8.

    Article  CAS  PubMed  Google Scholar 

  78. Colom F, Vieta E, Tacchi MJ, Sánchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005;7(Suppl 5):24–31.

    Article  PubMed  Google Scholar 

  79. Cuerda C, Velasco C, Merchán-Naranjo J, García-Peris P, Arango C. The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity. Eur J Clin Nutr. 2014;68(2):146–52.

    Article  CAS  PubMed  Google Scholar 

  80. Popovic D, Reinares M, Scott J, Nivoli A, Murru A, Pacchiarotti I, et al. Polarity index of psychological interventions in maintenance treatment of bipolar disorder. Psychother Psychosom. 2013;82(5):292–8.

    Article  PubMed  Google Scholar 

  81. Sylvia LG, Salcedo S, Bernstein EE, Baek JH, Nierenberg AA, Deckersbach T. Nutrition, exercise, and wellness treatment in bipolar disorder: proof of concept for a consolidated intervention. Int J Bipolar Disord. 2013;1(1):24. https://pubmed.ncbi.nlm.nih.gov/24660139.

    Article  PubMed  PubMed Central  Google Scholar 

  82. MacQueen GM, Marriott M, Begin H, Robb J, Joffe RT, Young LT. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord. 2003;5(5):349–55. https://doi.org/10.1034/j.1399-5618.2003.00048.x.

    Article  PubMed  Google Scholar 

  83. Geoffroy PA, Boudebesse C, Bellivier F, Lajnef M, Henry C, Leboyer M, et al. Sleep in remitted bipolar disorder: a naturalistic case-control study using actigraphy. J Affect Disord. 2014;158:1–7.

    Article  PubMed  Google Scholar 

  84. Samalin L, Boyer L, Murru A, Pacchiarotti I, Reinares M, Bonnin CM, et al. Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder. J Affect Disord. 2017;210:280–6.

    Article  PubMed  Google Scholar 

  85. De Dios C, Ezquiaga E, Agud JL, Vieta E, Soler B, García-López A. Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J Affect Disord. 2012;143(1):160–5. http://www.sciencedirect.com/science/article/pii/S0165032712004077.

    Article  PubMed  Google Scholar 

  86. Belzeaux R, Correard N, Boyer L, Etain B, Loftus J, Bellivier F, et al. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort. J Affect Disord. 2013;151(3):1009–15.

    Article  PubMed  Google Scholar 

  87. Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285–97. https://www.karger.com/DOI/10.1159/000228249.

    Article  CAS  PubMed  Google Scholar 

  88. Solé B, Bonnin CM, Torrent C, Balanzá-Martínez V, Tabarés-Seisdedos R, Popovic D, et al. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand. 2012;125(4):309–17.

    Article  PubMed  Google Scholar 

  89. del Mar Bonnín C, González-Pinto A, Solé B, Reinares M, González-Ortega I, Alberich S, et al. Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder. J Affect Disord. 2014;160:50–4.

    Article  Google Scholar 

  90. Samalin L, de Chazeron I, Vieta E, Bellivier F, Llorca P-M. Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 2016a;18(2):164–73.

    Article  PubMed  Google Scholar 

  91. Samalin L, Reinares M, de Chazeron I, Torrent C, Bonnin CM, Hidalgo-Mazzei D, et al. Course of residual symptoms according to the duration of euthymia in remitted bipolar patients. Acta Psychiatr Scand. 2016c;134(1):57–64. https://doi.org/10.1111/acps.12568.

    Article  CAS  PubMed  Google Scholar 

  92. Chengappa KNR, Baker RW, Shao L, Yatham LN, Tohen M, Gershon S, et al. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord. 2003;5(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  93. Tohen M, Zarate CAJ, Hennen J, Khalsa H-MK, Strakowski SM, Gebre-Medhin P, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003;160(12):2099–107.

    Article  PubMed  Google Scholar 

  94. Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221–5.

    Article  CAS  PubMed  Google Scholar 

  95. Zimmerman M, Chelminski I, Posternak M. A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol. 2004;19(1):1–7.

    Article  PubMed  Google Scholar 

  96. Vieta E, Torrent C. Functional remediation: the pathway from remission to recovery in bipolar disorder. World Psychiatry. 2016;15(3):288–9. https://pubmed.ncbi.nlm.nih.gov/27717267.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Barber ME. Recovery as the new medical model for psychiatry. Psychiatr Serv. 2012;63(3):277–9. https://doi.org/10.1176/appi.ps.201100248.

    Article  PubMed  Google Scholar 

  98. Dion GL, Tohen M, Anthony WA, Waternaux CS. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry. 1988;39(6):652–7.

    CAS  PubMed  Google Scholar 

  99. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1–2):103–13. https://doi.org/10.1111/j.1399-5618.2007.00327.x.

    Article  CAS  PubMed  Google Scholar 

  100. Harvey PD. Defining and achieving recovery from bipolar disorder. J Clin Psychiatry. 2006;67(Suppl 9):14–42.

    PubMed  Google Scholar 

  101. Ayuso-Mateos JL, Ávila CC, Anaya C, Cieza A, Vieta E. Development of the International Classification of Functioning, Disability and Health core sets for bipolar disorders: results of an international consensus process. Disabil Rehabil. 2013;35(25):2138–46. https://doi.org/10.3109/09638288.2013.771708.

    Article  PubMed  Google Scholar 

  102. Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE–RIFT): a brief measure of functional impairment. Psychol Med. 1999;29(4):869–78. https://www.cambridge.org/core/article/range-of-impaired-functioning-tool-liferift-a-brief-measure-of-functional-impairment/4B166D2568EC06E57CA3A869B8485437.

    Article  CAS  PubMed  Google Scholar 

  103. Jaeger J, Berns SM, Czobor P. The multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations. Schizophr Bull. 2003;29(1):153–67. https://doi.org/10.1093/oxfordjournals.schbul.a006987.

    Article  PubMed  Google Scholar 

  104. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Solé B, Bonnin CM, Jiménez E, Torrent C, Torres I, Varo C, et al. Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster-analytic approach. Acta Psychiatr Scand. 2018;137(6):516–27. https://doi.org/10.1111/acps.12871.

    Article  PubMed  Google Scholar 

  106. MacQueen GM, Young LT, Joffe RT. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand. 2001;103(3):163–70.

    Article  CAS  PubMed  Google Scholar 

  107. Solé B, Jiménez E, Torrent C, Reinares M, Bonnin CDM, Torres I, et al. Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol. 2017;20(8):670–80. https://www.ncbi.nlm.nih.gov/pubmed/28498954.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  108. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):441–5. https://doi.org/10.1017/S1461145708009498.

    Article  CAS  PubMed  Google Scholar 

  109. Morris G, Puri BK, Walker AJ, Maes M, Carvalho AF, Bortolasci CC, et al. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders. Neurosci Biobehav Rev. 2019;107:862–82. http://www.sciencedirect.com/science/article/pii/S0149763419304889.

    Article  CAS  PubMed  Google Scholar 

  110. Salagre E, Dodd S, Aedo A, Rosa A, Amoretti S, Pinzon J, et al. Toward precision psychiatry in bipolar disorder: staging 2.0. Front Psych. 2018;9:641.

    Article  Google Scholar 

  111. Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry. 2010;71(3):255–61.

    Article  PubMed  Google Scholar 

  112. Torrent C, Bonnin CM, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–9.

    Article  PubMed  Google Scholar 

  113. Forcada I, Mur M, Mora E, Vieta E, Bartrés-Faz D, Portella MJ. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2015;25(2):214–22.

    Article  CAS  Google Scholar 

  114. Reinares M. Psychotherapy for bipolar disorders: an integrative approach. Cambridge: Cambridge University Press; 2019. https://www.cambridge.org/core/books/psychotherapy-for-bipolar-disorders/39B0813F3749FDFB0B75426EEC627C04.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain

    Giovanna Fico, Gerard Anmella, Andrea Murru & Eduard Vieta

Authors
  1. Giovanna Fico
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerard Anmella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Murru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eduard Vieta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduard Vieta .

Editor information

Editors and Affiliations

  1. Department for Medical Sciences, Public Health, University of Cagliari, Cagliari, Italy

    Bernardo Carpiniello

  2. Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

    Antonio Vita

  3. Department of Neuroscience, Azienda Ospedaliera Fatebenefratelli e O, Milano, Italy

    Claudio Mencacci

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fico, G., Anmella, G., Murru, A., Vieta, E. (2022). Predictors of Clinical Recovery in Bipolar Disorders. In: Carpiniello, B., Vita, A., Mencacci, C. (eds) Recovery and Major Mental Disorders. Comprehensive Approach to Psychiatry, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-030-98301-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-98301-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-98300-0

  • Online ISBN: 978-3-030-98301-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation